Icotrokinra was safe and effective for improving skin clearance among patients with at least moderate psoriasis in ...

Patients with vs without MetS were associated with an increased risk for late-stage knee OA and more severe pain during early ...

The incidence and prevalence of CTD-ILD in the US is most common among women and older individuals, affecting approximately ...

The leading causes of readmission among patients who received THA included sepsis (14.6%), nonseptic infections (14.8%), cardiovascular events (11.2%), and pulmonary complications (8.4%). Common ...

Patients with axSpA who received UPA reported rapid and sustained improvements in total and nocturnal back pain over 12 weeks.

A multidisciplinary approach involving both pulmonologists and rheumatologists may lead to earlier ILD diagnosis among patients with SARDs.

Clinical improvements were achieved and maintained for up to 3 years among bDMARD-naïve patients with PsA who received bimekizumab.

Treatment with open-label tofacitinib improved disease activity among patients with sJIA but did not significantly prolong the time to flare compared with placebo.

Patients with systemic vasculitides vs healthy controls were associated with elevated risks for both osteoporosis and fragility fractures.

The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.

The cardiorespiratory effects of smoke fine particulate matter (PM2.5), a primary wildfire emission that can spike for months after a wildfire begins, can persist for months.

Research findings increasingly indicate close associations between autoimmune thyroid disease and rheumatic disease.